A Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix CEP of the European Pharmacopoeia monograph is often referred to as a Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix Certificate of Suitability (COS). The purpose of a Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix to their clients by showing that a Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix CEP has been issued for it. The manufacturer submits a Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix CEP (COS) as part of the market authorization procedure, and it takes on the role of a Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix CEP holder for the record. Additionally, the data presented in the Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix DMF.
A Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Nalidixic acid, NegGram, Nevigramon, Nalidixin, Uronidix suppliers with CEP (COS) on PharmaCompass.